STOCK TITAN

BioCardia (BCDA) Revenue by Year

BCDA NASDAQ

BioCardia, Inc. generated $0 in revenue in fiscal year 2025. This represents a decrease of 100.0% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters BioCardia, Inc. has filed alongside them.

FY2025 annual
Revenue $0
YoY -100.0%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BCDA Revenue by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Revenue$0-100.0%$58K-87.8%$477K-64.7%$1.4M+33.2%$1.0M+600.0%$145K-79.6%$710K+13.6%$625K+30.5%$479K-16.8%$576K-36.3%$904K

BCDA Revenue by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q/AQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q/AQ1'2410-QQ4'2310-K
RevenueN/AN/AN/A$0n/m$0n/m$0-100.0%$0-100.0%$0-100.0%$0-100.0%$3K-93.0%$55K-14.1%$13K-87.7%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More BioCardia, Inc. financials

Frequently Asked Questions

BioCardia, Inc. generated $0 in revenue in fiscal year 2025.

BioCardia, Inc. (BCDA) revenue fell by 100.0% year over year, from $58K to $0 in fiscal year 2025.

Across the 11 fiscal years this page covers, BioCardia, Inc. (BCDA) revenue went from $904K in fiscal year 2015 to $0 in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what BioCardia, Inc. (BCDA) reported on that line in every period on record.